Drug Shortage Report for TEVA-INDOMETHACIN
Report ID | 172010 |
Drug Identification Number | 00337420 |
Brand name | TEVA-INDOMETHACIN |
Common or Proper name | TEVA-INDOMETHACIN 25MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | INDOMETHACIN |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-17 |
Estimated end date | 2023-05-20 |
Actual end date | 2023-06-08 |
Shortage status | Resolved |
Updated date | 2023-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2023-06-09 | English | Compare |
v15 | 2023-06-08 | French | Compare |
v14 | 2023-06-08 | English | Compare |
v13 | 2023-04-27 | French | Compare |
v12 | 2023-04-27 | English | Compare |
v11 | 2022-12-22 | French | Compare |
v10 | 2022-12-22 | English | Compare |
v9 | 2022-12-08 | French | Compare |
v8 | 2022-12-08 | English | Compare |
v7 | 2022-12-01 | French | Compare |
v6 | 2022-12-01 | English | Compare |
v5 | 2022-11-11 | French | Compare |
v4 | 2022-11-11 | English | Compare |
v3 | 2022-10-18 | English | Compare |
v2 | 2022-10-17 | French | Compare |
v1 | 2022-10-17 | English | Compare |
Showing 1 to 16 of 16